Skip to main content
Top
Published in: BMC Ophthalmology 1/2007

Open Access 01-12-2007 | Research article

Idiopathic intracranial hypertension: the association between weight loss and the requirement for systemic treatment

Authors: Roger Wong, Stephen A Madill, Pravin Pandey, Paul Riordan-Eva

Published in: BMC Ophthalmology | Issue 1/2007

Login to get access

Abstract

Background

To determine whether weight loss is significantly associated with a discontinuation of treatment for idiopathic intracranial hypertension

Methods

The notes of 36 patients with idiopathic intracranial hypertension under regular review for at least 12 months by a single neuro-ophthalmologist were retrospectively reviewed. Weight was recorded at each assessment and weight loss recommended. Treatment was adjusted according to symptoms, visual function including visual fields and optic disc appearance only. Patients were divided according to duration of continuous follow-up, and then sub-divided as to whether they were on or not on treatment at most recent review and whether weight loss had been achieved compared to presentation. Survival analysis was performed to assess the probability of remaining on treatment having lost weight.

Results

Considering the patients as 3 groups, those with at least 12 months follow-up (n = 36), those with at least 18 months follow-up (n = 24) and those with 24 months or more follow-up (n = 19), only the group with 24 months or more follow-up demonstrated a significant association between weight loss and stopping systemic treatment (Fisher's exact test, p = 0.04). Survival analysis demonstrated that the probability of being on treatment at 5 years having gained weight was 0.63 and having lost weight was 0.38 (log rank test, p = 0.04). The results suggest that final absolute body mass index is more important than the change in body mass index for patients who stop treatment (Mann Whitney U, p = 0.05).

Conclusion

This is the first study to demonstrate that weight loss is associated with discontinuation of treatment. Unlike previous studies, our results suggest that final absolute body mass index is more important for stopping treatment than a proportional reduction in weight.
Appendix
Available only for authorised users
Literature
1.
go back to reference Kupersmith MJ, Gamell L, Turbin R, Peck V, Spiegel P, Wall M: Effects of weight loss on the course of idiopathic intracranial hypertension in women. Neurology. 1998, 50: 1094-1098.CrossRefPubMed Kupersmith MJ, Gamell L, Turbin R, Peck V, Spiegel P, Wall M: Effects of weight loss on the course of idiopathic intracranial hypertension in women. Neurology. 1998, 50: 1094-1098.CrossRefPubMed
2.
go back to reference Durcan FJ, Corbett JJ, Wall M: The incidence of pseudotumor cerebri. Population studies in Iowa and Louisiana. Arch Neurol. 1988, 45: 875-877.CrossRefPubMed Durcan FJ, Corbett JJ, Wall M: The incidence of pseudotumor cerebri. Population studies in Iowa and Louisiana. Arch Neurol. 1988, 45: 875-877.CrossRefPubMed
3.
go back to reference Wall G, George D: Idiopathic intracranial hypertension. Brain. 1991, 114: 155-180. 10.1093/brain/114.2.1112.CrossRefPubMed Wall G, George D: Idiopathic intracranial hypertension. Brain. 1991, 114: 155-180. 10.1093/brain/114.2.1112.CrossRefPubMed
4.
go back to reference Rowe FJ, Sarkies NJ: The relationship between obesity and idiopathic intracranial hypertension. Int J Obesity. 1999, 23: 54-59. 10.1038/sj.ijo.0800758.CrossRef Rowe FJ, Sarkies NJ: The relationship between obesity and idiopathic intracranial hypertension. Int J Obesity. 1999, 23: 54-59. 10.1038/sj.ijo.0800758.CrossRef
5.
go back to reference Daniels AB, Liu GT, Volpe NJ, Galetta SL, Moster ML, Newman NJ, Biousse V, Lee AG, Wall M, Kardon R, Acierno MD, Corbett JJ, Maguire MG, Balcer LJ: Profiles of obesity, weight gain, and quality of life in idiopathic intracranial hypertension (pseudotumor cerebri). Am J Ophthalmol. 2007, 143: 635-41. 10.1016/j.ajo.2006.12.040.CrossRefPubMed Daniels AB, Liu GT, Volpe NJ, Galetta SL, Moster ML, Newman NJ, Biousse V, Lee AG, Wall M, Kardon R, Acierno MD, Corbett JJ, Maguire MG, Balcer LJ: Profiles of obesity, weight gain, and quality of life in idiopathic intracranial hypertension (pseudotumor cerebri). Am J Ophthalmol. 2007, 143: 635-41. 10.1016/j.ajo.2006.12.040.CrossRefPubMed
6.
go back to reference Sugerman HJ, Felton WL, Salvant JB, Sismais A, Kellum JM: Effects of surgically induced weight loss on idiopathic intracranial hypertension in morbid obesity. Neurology. 1995, 45: 1655-1659.CrossRefPubMed Sugerman HJ, Felton WL, Salvant JB, Sismais A, Kellum JM: Effects of surgically induced weight loss on idiopathic intracranial hypertension in morbid obesity. Neurology. 1995, 45: 1655-1659.CrossRefPubMed
7.
go back to reference Newborg B: Pseudotumor cerebri treated by rice/reduction diet. Arch Intern Med. 1974, 133: 802-807. 10.1001/archinte.133.5.802.CrossRefPubMed Newborg B: Pseudotumor cerebri treated by rice/reduction diet. Arch Intern Med. 1974, 133: 802-807. 10.1001/archinte.133.5.802.CrossRefPubMed
8.
go back to reference Amaral JF, Tsiaris W, Morgan T, Thompson WR: Reversal of benign intracranial hypertension by surgically induced weight loss. Arch Surg. 1987, 122: 946-949.CrossRefPubMed Amaral JF, Tsiaris W, Morgan T, Thompson WR: Reversal of benign intracranial hypertension by surgically induced weight loss. Arch Surg. 1987, 122: 946-949.CrossRefPubMed
9.
go back to reference Johnson LN, Krohel GB, Madsen RW, March GA: The role of weight loss and acetazolamide in the treatment of idiopathic intracranial hypertension (pseudotumor cerebri). Ophthalmology. 1998, 105: 2313-2317. 10.1016/S0161-6420(98)91234-9.CrossRefPubMed Johnson LN, Krohel GB, Madsen RW, March GA: The role of weight loss and acetazolamide in the treatment of idiopathic intracranial hypertension (pseudotumor cerebri). Ophthalmology. 1998, 105: 2313-2317. 10.1016/S0161-6420(98)91234-9.CrossRefPubMed
10.
go back to reference Johnson I, Paterson A: Benign intracranial hypertension. II. CSF pressure and circulation. Brain. 1974, 97: 301-312. 10.1093/brain/97.1.301.CrossRef Johnson I, Paterson A: Benign intracranial hypertension. II. CSF pressure and circulation. Brain. 1974, 97: 301-312. 10.1093/brain/97.1.301.CrossRef
11.
go back to reference Mullholland DA, Craig JJ, Rankin SJA: Use of scanning laser ophthalmoscopy to monitor papilloedema in idiopathic intracranial hypertension. Br J Ophthalmol. 1998, 82: 1301-1305.CrossRef Mullholland DA, Craig JJ, Rankin SJA: Use of scanning laser ophthalmoscopy to monitor papilloedema in idiopathic intracranial hypertension. Br J Ophthalmol. 1998, 82: 1301-1305.CrossRef
12.
go back to reference Friedman DI, Jacobson DM: Diagnostic criteria for idiopathic intracranial hypertension. Neurology. 2002, 59: 1492-1495. 10.1001/archneur.59.9.1492.CrossRefPubMed Friedman DI, Jacobson DM: Diagnostic criteria for idiopathic intracranial hypertension. Neurology. 2002, 59: 1492-1495. 10.1001/archneur.59.9.1492.CrossRefPubMed
Metadata
Title
Idiopathic intracranial hypertension: the association between weight loss and the requirement for systemic treatment
Authors
Roger Wong
Stephen A Madill
Pravin Pandey
Paul Riordan-Eva
Publication date
01-12-2007
Publisher
BioMed Central
Published in
BMC Ophthalmology / Issue 1/2007
Electronic ISSN: 1471-2415
DOI
https://doi.org/10.1186/1471-2415-7-15

Other articles of this Issue 1/2007

BMC Ophthalmology 1/2007 Go to the issue